|
1
|
Hasina R and Lingen MW: Angiogenesis in
oral cancer. J Dent Educ. 65:1282–1290. 2001.PubMed/NCBI
|
|
2
|
Ascani G, Balercia P, Messi M, Lupi L,
Goteri G, Filosa A, Stramazzotti D, Pieramici T and Rubini C:
Angiogenesis in oral squamous cell carcinoma. Acta Otorhinolaryngol
Ital. 25:13–17. 2005.PubMed/NCBI
|
|
3
|
Blood CH and Zetter BR: Tumor interactions
with the vasculature: Angiogenesis and tumor metastasis. Biochim
Biophys Acta. 1032:89–118. 1990.PubMed/NCBI
|
|
4
|
Folkman J: What is the evidence that
tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fox SB, Gatter KC and Harris AL: Tumour
angiogenesis. J Pathol. 179:232–237. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferrara N and Keyt B: Vascular endothelial
growth factor: Basic biology and clinical implications. EXS.
79:209–232. 1997.PubMed/NCBI
|
|
7
|
Hicklin DJ and Ellis LM: Role of the
vascular endothelial growth factor pathway in tumor growth and
angiogenesis. J Clin Oncol. 23:1011–1027. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martano M, Maiolino P, Cataldi M and
Restucci B: Evaluation of angiogenesis by morphometric analysis of
blood vessels in dysplastic and neoplastic lesions of canine
gingiva. Vet Res Commun. 28(Suppl 1): 299–301. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tipoe GL, Jin Y and White FH: The
relationship between vascularity and cell proliferation in human
normal and pathological lesions of the oral cheek epithelium. Eur J
Cancer B Oral Oncol. 32B:24–31. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Khademi B, Soleimanpour M, Ghaderi A and
Mohammadianpanah M: Prognostic and predictive value of serum
vascular endothelial growth factor (VEGF) in squamous cell
carcinoma of the head and neck. Oral Maxillofac Surg. 18:187–196.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Al-Dissi AN, Haines DM, Singh B and Kidney
BA: Immunohistochemical expression of vascular endothelial growth
factor and vascular endothelial growth factor receptor associated
with tumor cell proliferation in canine cutaneous squamous cell
carcinomas and trichoepitheliomas. Vet Pathol. 44:823–830. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Restucci B, Borzacchiello G, Maiolino P,
Martano M, Paciello O and Papparella S: Expression of vascular
endothelial growth factor receptor Flk-1 in canine mammary tumours.
J Comp Pathol. 130:99–104. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Restucci B, Maiolino P, Paciello O,
Martano M, De Vico G and Papparella S: Evaluation of angiogenesis
in canine seminomas by quantitative immunohistochemistry. J Comp
Pathol. 128:252–259. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maiolino P, De Vico G and Restucci B:
Expression of vascular endothelial growth factor in basal cell
tumours and in squamous cell carcinomas of canine skin. J Comp
Pathol. 123:141–145. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sobczyńska-Rak A, Polkowska I and
Silmanowicz P: Elevated vascular endothelial growth factor (VEGF)
levels in the blood serum of dogs with malignant neoplasms of the
oral cavity. Acta Vet Hung. 62:362–371. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martano M, Damiano S, Restucci B, Paciello
O, Russo V and Maiolino P: Nuclear morphometry in canine
acanthomatous ameloblastomas and squamous cell carcinomas. Eur J
Histochem. 50:125–130. 2006.PubMed/NCBI
|
|
17
|
Head KW, Cullen JM, Dubielzig RR, Else RW,
Misdorp W, Patnaik AK, Tateyama S and van der Gaag I: Histological
classification of tumors of the alimentary system of domestic
animals (WHO). Armed Forces Institute of Pathology (Washington,
DC). 2003.
|
|
18
|
Pindborg JJ: Definition of terms related
to oral cancer and precancer. Oral cancer and precancer (Bristol).
John Wright & Sons. 2–19. 1980.Todoroff RJ and Brodey RS: Oral
and pharyngeal neoplasia in the dog: A retrospective survey of 361
cases. J Am Vet Med Assoc 175: 567–571, 1979.
|
|
19
|
Todoroff RJ and Brodey RS: Oral and
pharyngeal neoplasia in the dog: A retrospective survey of 361
cases. J Am Vet Med Assoc. 175:567–571. 1979.PubMed/NCBI
|
|
20
|
Mas A, Blackwood L, Cripps P, Murphy S, De
Vos J, Dervisis N, Martano M and Polton GA: Canine tonsillar
squamous cell carcinoma-a multi-centre retrospective review of 44
clinical cases. J Small Anim Pract. 52:359–364. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Restucci B, Maiolino P, Martano M, et al:
Expression of beta-catenin, E-cadherin and APC in canine mammary
tumors. Anticancer Res. 27:3083–3089. 2007.PubMed/NCBI
|
|
22
|
Restucci B, Martano M, De Vico G, et al:
Expression of E-cadherin, beta-catenin and APC protein in canine
colorectal tumours. Anticancer Res. 29:2919–2925. 2009.PubMed/NCBI
|
|
23
|
Martano M, Carella F, Squillacioti C, et
al: Metallothionein expression in canine cutaneous apocrine gland
tumors. Anticancer Res. 32:747–752. 2012.PubMed/NCBI
|
|
24
|
Turley H, Scott PA, Watts VM, et al:
Expression of VEGF in routinely fixed material using a new
monoclonal antibody VG1. J Pathol. 186:313–318. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Head KWER and Dubielzig RR: Tumors of the
alimentary tract. Tumors in Domestic Animals. Press IS: (Ames). DJ
Meuten. 401–481. 2002.
|
|
26
|
Ferrara N and Davis-Smyth T: The biology
of vascular endothelial growth factor. Endocr Rev. 18:4–25. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dvorak HF, Detmar M, Claffey KP, Nagy JA,
van de Water L and Senger DR: Vascular permeability factor/vascular
endothelial growth factor: An important mediator of angiogenesis in
malignancy and inflammation. Int Arch Allergy Immunol. 107:233–235.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Denhart BC, Guidi AJ, Tognazzi K, Dvorak
HF and Brown LF: Vascular permeability factor/vascular endothelial
growth factor and its receptors in oral and laryngeal squamous cell
carcinoma and dysplasia. Lab Invest. 77:659–664. 1997.PubMed/NCBI
|
|
30
|
Neufeld G, Cohen T, Gengrinovitch S and
Poltorak Z: Vascular endothelial growth factor (VEGF) and its
receptors. FASEB J. 13:9–22. 1999.PubMed/NCBI
|
|
31
|
Margaritescu C, Pirici D, Simionescu C,
Mogoantă L, Raica M, Stîngă A, Ciurea R, Stepan A, Stîngă A and
Ribatti D: VEGF and VEGFRs expression in oral squamous cell
carcinoma. Rom J Morphol Embryol. 50:527–548. 2009.PubMed/NCBI
|
|
32
|
Johnstone S and Logan RM: The role of
vascular endothelial growth factor (VEGF) in oral dysplasia and
oral squamous cell carcinoma. Oral Oncol. 42:337–342. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cross MJ and Claesson-Welsh L: FGF and
VEGF function in angiogenesis: Signalling pathways, biological
responses and therapeutic inhibition. Trends Pharmacol Sci.
22:201–207. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maeda T, Matsumura S, Hiranuma H, Jikko A,
Furukawa S, Ishida T and Fuchihata H: Expression of vascular
endothelial growth factor in human oral squamous cell carcinoma:
Its association with tumour progression and p53 gene status. J Clin
Pathol. 51:771–775. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shintani S, Li C, Ishikawa T, Mihara M,
Nakashiro K, et al: Expression of vascular endothelial growth
factor A, B, C and D in oral squamous cell carcinoma. Oral Oncol.
40:13–20. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shang ZJ and Li JR: Expression of
endothelial nitric oxide synthase and vascular endothelial growth
factor in oral squamous cell carcinoma: Its correlation with
angiogenesis and disease progression. J Oral Pathol Med.
34:134–139. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Salven P, Heikkila P, Anttonen A, Kajanti
M and Joensuu H: Vascular endothelial growth factor in squamous
cell head and neck carcinoma: Expression and prognostic
significance. Mod Pathol. 10:1128–1133. 1997.PubMed/NCBI
|
|
38
|
Tae K, El-Naggar AK, Yoo E, Feng L, Lee
JJ, Hong WK, Hittelman WN and Shin DM: Expression of vascular
endothelial growth factor and microvessel density in head and neck
tumorigenesis. Clin Cancer Res. 6:2821–2828. 2000.PubMed/NCBI
|
|
39
|
Baillie R, Harada K, Carlile J, Macluskey
M, Schor SL and Schor AM: Expression of vascular endothelial growth
factor in normal and tumour oral tissues assessed with different
antibodies. Histochem J. 33:287–294. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Levy NS, Chung S, Furneaux H and Levy AP:
Hypoxic stabilization of vascular endothelial growth factor mRNA by
the RNA-binding protein HuR. J Biol Chem. 273:6417–6423. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Grugel S, Finkenzeller G, Weindel K,
Barleon B and Marmé D: Both v-Ha-Ras and v-Raf stimulate expression
of the vascular endothelial growth factor in NIH 3T3 cells. J Biol
Chem. 270:25915–25919. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rak J, Filmus J, Finkenzeller G, Grugel S,
Marmé D and Kerbel RS: Oncogenes as inducers of tumor angiogenesis.
Cancer Metastasis Rev. 14:263–277. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rak J, Mitsuhashi Y, Bayko L, Filmus J,
Shirasawa S, Sasazuki T and Kerbel RS: Mutant ras oncogenes
upregulate VEGF/VPF expression: Implications for induction and
inhibition of tumor angiogenesis. Cancer Res. 55:4575–4580.
1995.PubMed/NCBI
|
|
44
|
Tsai ST and Jin YT: Proliferating cell
nuclear antigen (PCNA) expression in oral squamous cell carcinomas.
J Oral Pathol Med. 24:313–315. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kato K, Kawashiri S, Yoshizawa K, et al:
Expression form of p53 and PCNA at the invasive front in oral
squamous cell carcinoma: Correlation with clinicopathological
features and prognosis. J Oral Pathol Med. 40:693–698. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Millanta F, Silvestri G, Vaselli C, et al:
The role of vascular endothelial growth factor and its receptor
Flk-1/KDR in promoting tumour angiogenesis in feline and canine
mammary carcinomas: A preliminary study of autocrine and paracrine
loops. Res Vet Sci. 81:350–357. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Restucci B, Papparella S, Maiolino P and
De Vico G: Expression of vascular endothelial growth factor in
canine mammary tumors. Vet Pathol. 39:488–493. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Breward CJW, Byrne HM and Lewis CE:
Modelling the interactions between tumour cells and a blood vessel
in a microenvironment within a vascular tumour. Eur J Appl Math.
12:529–556. 2001. View Article : Google Scholar
|
|
49
|
de Jong JS, van Diest PJ, van der Valk P
and Baak JP: Expression of growth factors, growth-inhibiting
factors and their receptors in invasive breast cancer. II:
Correlations with proliferation and angiogenesis. J Pathol.
184:53–57. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rosen LS: VEGF-targeted therapy:
Therapeutic potential and recent advances. Oncologist. 10:382–391.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bjorndahl M, Cao R, Eriksson A and Cao Y:
Blockage of VEGF-induced angiogenesis by preventing VEGF secretion.
Circ Res. 94:1443–1450. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kim KJ, Li B, Winer J, Armanini M, Gillett
N, et al: Inhibition of vascular endothelial growth factor-induced
angiogenesis suppresses tumour growth in vivo. Nature.
362:841–844. 1993. View Article : Google Scholar : PubMed/NCBI
|
